MedTrace Logo

Left Main Coronary Artery Stenosis and Angioplasty With Taxus Stent

NCT00300157 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 155

Last updated 2011-01-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether percutaneous coronary angioplasty with Taxus drug eluting stent is safe and effective in the treatment of unprotected left main coronary artery disease associated to other coronary lesions or not.

Conditions

  • Coronary Arteriosclerosis

Interventions

DEVICE

Percutaneous coronary intervention with Taxus stent

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • French Cardiology Society

    lead OTHER

Principal Investigators

  • Didier Carrié, MD-PhD · Rangueil Hospital Toulouse France

  • Hélène ELTCHANINOFF, MD-PhD · Hôpital Charles Nicolle Rouen FRANCE

  • Thierry LEFEVRE, MD · Hôpital Jacques Cartier ICPS Massy FRANCE

  • Marc SILVESTRI, MD · Polyclinique du Parc Rambot Aix en Provence FRANCE

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00300157 on ClinicalTrials.gov